METRO HEALTHCARE BERHAD
KLSE (MYR): MHCARE (03005)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
Today's Change
Day's Change
Trading Volume
Financial
Market Cap
Market Cap
382 Million
NOSH
822 Million
Latest Quarter
Latest Quarter
30-Jun-2024 [#1]
Announcement Date
29-Aug-2024
Next Quarter
30-Sep-2024
Est. Ann. Date
29-Nov-2024
Est. Ann. Due Date
29-Nov-2024
QoQ | YoY
18.11% | 8.60%
T4Q Result
Revenue | NP to SH
47,468.000 | 6,528.000
RPS | P/RPS
5.77 Cent | 8.06
EPS | P/E | EY
0.79 Cent | 58.57 | 1.71%
DPS | DY | Payout %
0.54 Cent | 1.16% | 68.02%
NAPS | P/NAPS
0.04 | 10.50
QoQ | YoY
4.48% | 14.11%
NP Margin | ROE
13.75% | 17.91%
F.Y. | Ann. Date
30-Jun-2024 | 29-Aug-2024
Latest Audited Result
Latest Audited Result
31-Dec-2023
Announcement Date
29-Feb-2024
Next Audited Result
31-Dec-2024
Est. Ann. Date
28-Feb-2025
Est. Ann. Due Date
29-Jun-2025
Annual (Unaudited)
Revenue | NP to SH
44,686.000 | 6,248.000
RPS | P/RPS
5.43 Cent | 8.56
EPS | P/E | EY
0.76 Cent | 61.20 | 1.63%
DPS | DY | Payout %
0.52 Cent | 1.12% | 69.09%
NAPS | P/NAPS
0.05 | 10.22
YoY
22.77%
NP Margin | ROE
13.98% | 16.72%
F.Y. | Ann. Date
31-Dec-2023 | 23-Feb-2024
Annualized Result
Revenue | NP to SH
48,968.000 | 7,070.000
RPS | P/RPS
5.96 Cent | 7.81
EPS | P/E | EY
0.86 Cent | 54.08 | 1.85%
DPS | DY | Payout %
-
NAPS | P/NAPS
-
QoQ | YoY
13.16% | 8.6%
NP Margin | ROE
14.44% | 19.40%
F.Y. | Ann. Date
30-Jun-2024 | 29-Aug-2024
Business Process
| Trailing 4 Quarters | Trailing 8 Quarters | |||
|---|---|---|---|---|
| Available Quarters | 4 Quarters | 8 Quarters | ||
| Continuous Quarters Of Revenue Growth | 4 / 4 | 100.00% | 4 / 8 | 50.00% |
| Total Positive Profit Years | 4 / 4 | 100.00% | 8 / 8 | 100.00% |
| Continuous Quarters Of Positive Profit | 4 / 4 | 100.00% | 8 / 8 | 100.00% |
| Continuous Quarters Of Profit Growth | 1 / 4 | 25.00% | 1 / 8 | 12.50% |
| Continuous Quarters Of Adjusted EPS Growth | 1 / 4 | 25.00% | 1 / 8 | 12.50% |
| Total Dividend Years | 2 / 4 | 50.00% | 6 / 8 | 75.00% |
| Continuous Quarters Of Dividend | 1 / 4 | 25.00% | 1 / 8 | 12.50% |
| Continuous Quarters Of Dividend Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
| Continuous Quarters Of Adjusted Dps Growth | 1 / 4 | 25.00% | 1 / 8 | 12.50% |
| Average ROE | 8.58% | 13.01% | ||
| Average Net Profit Margin | 13.58% | 16.59% | ||
| Last 5 Financial Years | Last 10 Financial Years | |||
|---|---|---|---|---|
| Available Years | 5 Years | 10 Years | ||
| Continuous Quarters Of Revenue Growth | 1 / 5 | 20.00% | 1 / 8 | 12.50% |
| Total Positive Profit Years | 5 / 5 | 100.00% | 7 / 8 | 87.50% |
| Continuous Quarters Of Positive Profit | 5 / 5 | 100.00% | 7 / 8 | 87.50% |
| Continuous Quarters Of Profit Growth | 1 / 5 | 20.00% | 1 / 8 | 12.50% |
| Continuous Quarters Of Adjusted EPS Growth | 1 / 5 | 20.00% | 1 / 8 | 12.50% |
| Total Dividend Years | 5 / 5 | 100.00% | 5 / 8 | 62.50% |
| Continuous Quarters Of Dividend | 5 / 5 | 100.00% | 5 / 8 | 62.50% |
| Continuous Quarters Of Dividend Growth | 4 / 5 | 80.00% | 4 / 8 | 50.00% |
| Continuous Quarters Of Adjusted Dps Growth | 5 / 5 | 100.00% | 5 / 8 | 62.50% |
| Average ROE | 25.28% | 18.99% | ||
| Average Net Profit Margin | 15.63% | 87.67% | ||
Key Result
| T4Q | Annualized | Annual (Unaudited) | Last 10 FY Average | Last 5 FY Average | |
|---|---|---|---|---|---|
| Revenue | 47,468 | 48,968 | 44,686 | 24,847 | 35,651 |
| NP to SH | 6,528 | 7,070 | 6,248 | 3,973 | 5,691 |
| Dividend | 4,440 | 8,880 | 4,316 | 1,576 | 2,523 |
| Adjusted EPS | 0.79 | 0.86 | 0.76 | 0.64 | 0.92 |
| Adjusted DPS | 0.54 | 1.08 | 0.52 | 0.26 | 0.41 |
NP to SH = Net Profit Attributable to Shareholder, EPS = Earning Per Share, DPS = Dividend Per Share
All figures in '000 unless specified.
EPS & DPS's figures in Cent.
Growth
| LQ QoQ | LQ YoY | CQ YoY | LQ vs Average of T4Q | LQ vs Average of T8Q | |
|---|---|---|---|---|---|
| Revenue | 6.53% | 12.82% | 12.82% | 8.89% | 15.97% |
| NP to Owner | 18.11% | 8.60% | 8.60% | 15.44% | 1.77% |
| Dividend | 0.00% | 2.86% | 2.86% | 102.82% | 105.56% |
| Adjusted EPS | 16.33% | 7.55% | 7.55% | 14.57% | 1.01% |
| Adjusted DPS | 0.00% | 2.86% | 2.86% | 102.82% | 105.56% |
LQ = Latest Quarter, CQ = Cumulative Quarter, T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, QoQ = Quarter on Quarter, YoY = Year on Year
| T4Q vs LFY | T4Q vs AL5FY | T4Q vs AL10FY | AQR vs LFY | AQR vs AL5FY | AQR vs AL10FY | LFY YoY | LFY vs AL5FY | LFY vs AL10FY | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.23% | 33.14% | 91.04% | 9.58% | 37.35% | 97.07% | 10.96% | 25.34% | 79.84% |
| NP to Owner | 4.48% | 14.69% | 64.29% | 13.16% | 24.21% | 77.93% | 22.77% | 9.77% | 57.25% |
| Dividend | 2.86% | 75.99% | 181.58% | 105.71% | 251.98% | 463.16% | 6.06% | 71.10% | 173.76% |
| Adjusted EPS | 4.95% | 14.81% | 64.47% | 12.87% | 23.47% | 76.88% | 21.69% | 9.39% | 56.71% |
| Adjusted DPS | 2.86% | 75.99% | 181.58% | 105.71% | 251.98% | 463.16% | 6.06% | 71.10% | 173.76% |
T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, AL5FY = Average of Last 5 Financial Years, AL10FY = Average of Last 10 Financial Years, LFY = Latest Financial Year AQR = Annualized Quarter Result, YoY = Year on Year
Discussions
Be the first to like this. Showing 38 of 37 comments
With loads of govt support and initiativea to promote ferrility treatment, which is their core strength.. this counter will only gain further
2019-10-21 21:54
this company is focused on Assisted reproductive technology with high success rate on their IVF treatment.. definitely a diamond in the making..
2021-05-27 07:48
Hurray..just received bonus share issue.. 2 for 1.. looking forward to another climb..
2021-10-23 11:54
Integrity. Intelligent. Industrious. 3iii (iiinvestsmart)$€£¥
This counter listed on IPO at 25 sen per share in 2018.
After 2 for 1 bonus, it is now 57 sen per share.
The initial investors have seen their investment per share rising from 25 sen per share to 57 x 3 = 171 sen per share (a 6 multi-bagger).
Dividends were distributed annually.
MHCare is in assisted reproductive technology. It is among the leaders providing this service in Malaysia. It benefits from health tourism which is promoted by the Malaysian government. It is growing its services in various parts of Malaysia consistently.
2022-02-15 17:46
This company is having a great run due to their focus in the niche market which involved fertility treatment coupled with their targeted expansion and coverage This has lead to a great 2H 2021 thus ending another strong full year 2021.
With a capable management who has clear objectives for strong growth and sustainability, will look forward to another grear 2022 and beyond..
2022-02-23 13:17
Saw Metro Healthcare featured in TIME Magazine Person Of The Year 2022/2023. Kudos https://link.emagazines.com/?t=6DAE8BFD-8365-47B6-A3DA-9CBA14D36A7C
2023-01-04 12:32
Totally different..
Company with good and strong fundamentals..
And very focused in highly specialised market of Assisted Reproductive Technology (ART), eg IVF
1 month ago
03005 MHCARE, METRO HEALTHCARE BERHAD - +
MHCARE - WITHDRAWAL OF LISTING FROM THE LEAP MARKET
8 Nov 2024, 14:14
MHCARE - WITHDRAWAL OF LISTING FROM THE LEAP MARKET
MHCARE - WITHDRAWAL OF LISTING FROM THE LEAP MARKET
ILC-04112024-00014
Please be advised that: 1) Pursuant to Rule 8.02(1) of the LEAP Market
Listing Requirements (?LEAP LR?), the trading in the shares of MHCARE will be
suspended with effect from 9.00 a.m., Tuesday, 12 November 2024; and 2)
Pursuant to Rule 8.05 and 8.06 of the LEAP LR, the entire issued shares of
MHCARE will be removed from the LEAP Market of Bursa Securities with effect
from 9.00 a.m., Friday, 15 November 2024, to facilitate the transfer of the
entire issued shares of MHCARE from LEAP Market to the ACE Market. Your
attention is drawn to the Company's announcement dated 1 November 2024.
Vice President, Issuers, Listing
You are advised to read the entire contents of the announcement or attachment.
To read the entire contents of the announcement or attachment, please access
the Bursa website at http://www.bursamalaysia.com
1 month ago
MHCare will continue the trend.. of Steel Hawk.. being the 2nd counter to move from LEAP to ACE
1 month ago
They offer more complete women's healthcare services as they have maternity hospitals, women's clinics, in addition to their fertility treatment services..
1 month ago
Dow Jones
Dow Jones Industrial Average
43,737.80
-220.39
0.50%
Nasdaq
NASDAQ Composite
19,113.87
-116.84
0.60%
1 month ago
Name
Last
High
Low
Chg.
Chg. %
Time
US 30
43,542.8 43,762.8 43,535.2 -208.1 -0.48%
02:51:41
US 500
5,917.1 5,947.9 5,916.4 -32.1 -0.54%
02:51:28
US Tech 100
20,749.0 20,872.8 20,727.5 -149.7 -0.72%
02:52:24
1 month ago
2024-11-15
Price Target
Metro Healthcare Berhad - Easing Healthcare Accessibility
Source : Rakuten, Price Call : BUY, Price Target : 0.29
Last Price : 0.465, Upside/Downside : -0.175(37.63%)
1 month ago
Post a Comment
Featured Posts
Latest Videos
Apps
Top Articles
1
Stock Market Enthusiast
Top 3 AI/Data Center Newsflow for the 3rd Week of December - #TENAGA, #YTL, #YTLPOWER
2
Rakuten Trade Research Reports
3
save malaysia!
4
Good Articles to Share
5
Good Articles to Share
World’s largest stablecoin issuer Tether sees US$10b in net profits for 2024
6
Good Articles to Share
Honda and Nissan consider mutual production of vehicles, Kyodo reports
7
Good Articles to Share
8
Good Articles to Share
Economy won’t ‘radically change’ in 2025, strategist predicts
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
sptay
Health company specialising in women 's health and IVF.
2018-02-27 23:34